Synthesis and preliminary investigations into novel 1,2,3-triazole-derived androgen receptor antagonists inspired by bicalutamide

Jarrad M Altimari, Birunthi Niranjan, Gail P Risbridger, Stephanie S Schweiker, Anna E Lohning, Luke C Henderson

Research output: Contribution to journalArticleResearchpeer-review

9 Citations (Scopus)


A versatile and high yielding synthesis of novel androgen receptor (AR) antagonists is presented. Using this methodology, six 1,4-substituted-1,2,3-triazole derived bicalutamide mimics were synthesised in five steps and in isolated overall yields from 41 to 85 . Evaluation of these compounds for their anti-proliferative properties against androgen dependent (LNCaP) and independent (PC-3) cells showed promising IC50 values of 34-45 muM and 29-151 muM, respectively. The data suggest that the latter compounds may be an excellent starting point for the development of prostate cancer therapeutics for both androgen dependent and independent forms of this disease. Docking of these compounds (each enantiomer) in silico into the T877A mutated androgen receptor, as possessed by LNCaP cells, was also undertaken.
Original languageEnglish
Pages (from-to)4948 - 4953
Number of pages6
JournalBioorganic and Medicinal Chemistry Letters
Issue number21
Publication statusPublished - 2014

Cite this